Nitric	O
oxide-stimulated	O
guanine	O
nucleotide	O
exchange	O
on	O
p21ras	B-protein
.	O

The	O
protooncogene	B-DNA
p21ras	I-DNA
,	O
a	O
monomeric	B-protein
G	I-protein
protein	I-protein
family	I-protein
member	I-protein
,	O
plays	O
a	O
critical	O
role	O
in	O
converting	O
extracellular	O
signals	O
into	O
intracellular	O
biochemical	O
events	O
.	O

Here	O
,	O
we	O
report	O
that	O
nitric	O
oxide	O
(	O
NO	O
)	O
activates	O
p21ras	B-DNA
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
as	O
evidenced	O
by	O
an	O
increase	O
in	O
GTP-bound	B-protein
p21ras	I-protein
.	O

In	O
vitro	O
studies	O
using	O
pure	B-protein
recombinant	I-protein
p21ras	I-protein
demonstrate	O
that	O
the	O
activation	O
is	O
direct	O
and	O
reversible	O
.	O

Circular	O
dichroism	O
analysis	O
reveals	O
that	O
NO	O
induces	O
a	O
profound	O
conformational	O
change	O
in	O
p21ras	B-DNA
in	O
association	O
with	O
GDP/GTP	O
exchange	O
.	O

The	O
mechanism	O
of	O
activation	O
is	O
due	O
to	O
S-nitrosylation	O
of	O
a	O
critical	O
cysteine	O
residue	O
which	O
stimulates	O
guanine	O
nucleotide	O
exchange	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
p21ras	B-protein
is	O
essential	O
for	O
NO-induced	O
downstream	O
signaling	O
,	O
such	O
as	O
NF-kappa	B-protein
B	I-protein
activation	O
,	O
and	O
that	O
endogenous	O
NO	O
can	O
activate	O
p21ras	B-protein
in	O
the	O
same	O
cell	O
.	O

These	O
studies	O
identify	O
p21ras	B-DNA
as	O
a	O
target	O
of	O
the	O
same	O
cell	O
.	O

These	O
studies	O
identify	O
p21ras	B-DNA
as	O
a	O
target	O
of	O
NO	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
suggest	O
that	O
NO	O
activates	O
p21ras	B-DNA
by	O
an	O
action	O
which	O
mimics	O
that	O
of	O
guanine	B-protein
nucleotide	I-protein
exchange	I-protein
factors	I-protein
.	O

Communication	NULL
Nitric	NULL
Oxide-stimulated	NULL
Guanine	NULL
Nucleotide	NULL
Exchange	NULL
on	NULL
p21	NULL
``	NULL
``	NULL
**	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
30	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
1	NULL
,	NULL
1995	NULL
)	NULL
Harry	NULL
M.	NULL
Lander	NULL
#	NULL
§	NULL
,	NULL
Jason	NULL
S.	NULL
Ogiste	NULL
?	NULL

t	NULL
,	NULL
S.	NULL
Frieda	NULL
A.	NULL
Pearce	NULL
,	NULL
Roberto	NULL
Levit	NULL
,	NULL
and	NULL
Abraham	NULL
Novogrodsky|**	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Pharmacology	NULL
and	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
/	NULL
Oncology	NULL
,	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
,	NULL
the	NULL
Felsenstein	NULL
Medical	NULL
Research	NULL
Center	NULL
,	NULL
Beilinson	NULL
Campus	NULL
,	NULL
Petah-Tikva	NULL
49100	NULL
,	NULL
Israel	NULL
,	NULL
and	NULL
the	NULL
**Sackler	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Tel	NULL
Aviv	NULL
University	NULL
,	NULL
Tel	NULL
Aviv	NULL
69978	NULL
,	NULL
Israel	NULL
The	NULL
protooncogene	NULL
p21	NULL
``	NULL
,	NULL
a	NULL
monomeric	NULL
G	NULL
protein	NULL
family	NULL
member	NULL
,	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
converting	NULL
extra-cellular	NULL
signals	NULL
into	NULL
intracellular	NULL
biochemical	NULL
events	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
that	NULL
nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
activates	NULL
p21l	NULL
'	NULL
``	NULL
*	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
as	NULL
evidenced	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
GTP	NULL
bound	NULL
p21	NULL
``	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
using	NULL
pure	NULL
recombinant	NULL
p21	NULL
``	NULL
demonstrate	NULL
that	NULL
the	NULL
activation	NULL
is	NULL
direct	NULL
and	NULL
re-versible	NULL
.	NULL

Circular	NULL
dichroism	NULL
analysis	NULL
reveals	NULL
that	NULL
NO	NULL
induces	NULL
a	NULL
profound	NULL
conformational	NULL
change	NULL
in	NULL
p21	NULL
*	NULL
``	NULL
``	NULL
in	NULL
association	NULL
with	NULL
GDP/GTP	NULL
exchange	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
activation	NULL
is	NULL
due	NULL
to	NULL
S-nitrosylation	NULL
of	NULL
a	NULL
critical	NULL
cysteine	NULL
residue	NULL
which	NULL
stimulates	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
p21	NULL
``	NULL
is	NULL
essential	NULL
for	NULL
NO-induced	NULL
downstream	NULL
signaling	NULL
,	NULL
such	NULL
as	NULL
NF-KB	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
endogenous	NULL
NO	NULL
can	NULL
activate	NULL
p21	NULL
``	NULL
``	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
.	NULL

These	NULL
studies	NULL
identify	NULL
p21	NULL
``	NULL
**	NULL
as	NULL
a	NULL
target	NULL
of	NULL
NO	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
suggest	NULL
that	NULL
NO	NULL
activates	NULL
p21	NULL
``	NULL
by	NULL
an	NULL
action	NULL
which	NULL
mimics	NULL
that	NULL
of	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factors	NULL
.	NULL

Reactive	NULL
oxygen	NULL
species	NULL
are	NULL
known	NULL
to	NULL
mediate	NULL
signal	NULL
transduction	NULL
events	NULL
in	NULL
lymphocytes	NULL
(	NULL
1-3	NULL
)	NULL
and	NULL
have	NULL
recently	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
signaling	NULL
process	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
stimuli	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
reactive	NULL
nitrogen	NULL
species	NULL
,	NULL
nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
,	NULL
!	NULL

plays	NULL
critical	NULL
roles	NULL
in	NULL
many	NULL
diverse	NULL
biological	NULL
processes	NULL
such	NULL
as	NULL
vasoregulation	NULL
,	NULL
host	NULL
defense	NULL
and	NULL
synaptic	NULL
plasticity	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
role	NULL
for	NULL
NO	NULL
as	NULL
a	NULL
positive	NULL
signaling	NULL
molecule	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
protooncogene	NULL
p21	NULL
**	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
key	NULL
molecular	NULL
switch	NULL
involved	NULL
in	NULL
regulating	NULL
T	NULL
cell	NULL
activation	NULL
triggered	NULL
by	NULL
various	NULL
mitogens	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
immune	NULL
stimulatory	NULL
properties	NULL
of	NULL
NO	NULL
may	NULL
be	NULL
mediated	NULL
through	NULL
p21	NULL
``	NULL
,	NULL
and	NULL
thus	NULL
we	NULL
examined	NULL
whether	NULL
NO	NULL
could	NULL
activate	NULL
p21	NULL
**	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
HL34215	NULL
,	NULL
HL46403	NULL
,	NULL
and	NULL
HLO7423	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Biochemis-try	NULL
,	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
212-746-6462	NULL
;	NULL
Fax	NULL
:	NULL
212-746-8789	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NO	NULL
,	NULL
nitric	NULL
oxide	NULL
;	NULL
HUVEC	NULL
,	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
;	NULL
GEF	NULL
,	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factors	NULL
.	NULL

THE	NULL
JourNaAL	NULL
or	NULL
BroLocICaL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

13	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
31	NULL
,	NULL
pp	NULL
.	NULL

7017-7020	NULL
,	NULL
1995	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Nitric	NULL
oxide	NULL
and	NULL
carbon	NULL
monoxide	NULL
gas	NULL
were	NULL
purchased	NULL
from	NULL
Matheson	NULL
Gas	NULL
,	NULL
East	NULL
Rutherford	NULL
,	NULL
NJ	NULL
;	NULL
[	NULL
y-°°P	NULL
]	NULL
IGTP	NULL
and	NULL
PO	NULL
;	NULL
were	NULL
from	NULL
Amersham	NULL
Corp.	NULL
;	NULL
p21	NULL
``	NULL
**	NULL
antibodies	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotech-nology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
;	NULL
and	NULL
all	NULL
other	NULL
biochemicals	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Purified	NULL
,	NULL
recombinant	NULL
p21	NULL
``	NULL
**	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Daniel	NULL
Manor	NULL
,	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Cornell	NULL
University	NULL
,	NULL
Ithaca	NULL
,	NULL
NY	NULL
.	NULL

Cell	NULL
Culture-The	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
a	NULL
37	NULL
°C	NULL
incubator	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HU-VEC	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Steven	NULL
S.	NULL
Gross	NULL
,	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
and	NULL
PC12	NULL
mutant	NULL
cells	NULL
by	NULL
Dr.	NULL
G.	NULL
Cooper	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Quantitation	NULL
of	NULL
p21	NULL
'	NULL
%	NULL
®-associated	NULL
Nucleotides-The	NULL
assay	NULL
used	NULL
to	NULL
measure	NULL
the	NULL
GTP/GDP	NULL
ratio	NULL
on	NULL
immunoprecipitated	NULL
p21	NULL
``	NULL
**	NULL
was	NULL
essentially	NULL
that	NULL
of	NULL
Downward	NULL
et	NULL
ol	NULL
.	NULL

(	NULL
11	NULL
)	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells/ml	NULL
!	NULL
)	NULL

were	NULL
labeled	NULL
in	NULL
phosphate-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
200	NULL
mCi/ml	NULL
*°POz	NULL
for	NULL
16	NULL
h.	NULL
NO	NULL
,	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
,	NULL
was	NULL
added	NULL
directly	NULL
to	NULL
1	NULL
ml	NULL
of	NULL
sample	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
which	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
percentage	NULL
of	NULL
GTP-bound	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
*	NULL
.	NULL

Anti-p21	NULL
``	NULL
``	NULL
®-agarose	NULL
(	NULL
clone	NULL
Y13-259	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
was	NULL
added	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

After	NULL
elution	NULL
of	NULL
guanine	NULL
nucleotides	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
sample	NULL
was	NULL
spotted	NULL
onto	NULL
polyethyleneimine	NULL
TLC	NULL
plates	NULL
,	NULL
run	NULL
for	NULL
3	NULL
h	NULL
in	NULL
0.75	NULL
m	NULL
KH	NULL
,	NULL
PO	NULL
,	NULL
(	NULL
pH	NULL
3.4	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
phosphorimaging	NULL
screens	NULL
overnight	NULL
.	NULL

Spots	NULL
migrating	NULL
with	NULL
the	NULL
same	NULL
R	NULL
,	NULL
as	NULL
GDP	NULL
or	NULL
GTP	NULL
standards	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
GTP	NULL
bound	NULL
to	NULL
p21	NULL
*	NULL
was	NULL
calculated	NULL
using	NULL
the	NULL
following	NULL
formula	NULL
which	NULL
takes	NULL
into	NULL
account	NULL
the	NULL
extra	NULL
phosphate	NULL
on	NULL
GTP	NULL
as	NULL
compared	NULL
with	NULL
GDP	NULL
:	NULL
(	NULL
%	NULL
x	NULL
GTPY/	NULL
(	NULL
GDP	NULL
+	NULL
%	NULL
x	NULL
GTP	NULL
)	NULL
.	NULL

Control	NULL
samples	NULL
had	NULL
non-immune	NULL
IgG	NULL
+	NULL
protein	NULL
A-agarose	NULL
added	NULL
rather	NULL
than	NULL
anti-p21	NULL
'	NULL
``	NULL
``	NULL
,	NULL
and	NULL
no	NULL
GDP	NULL
or	NULL
GTP	NULL
spots	NULL
were	NULL
evident	NULL
.	NULL

GTPase	NULL
Assay-The	NULL
GTPase	NULL
assay	NULL
was	NULL
performed	NULL
exactly	NULL
as	NULL
we	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Carbon	NULL
monoxide	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
saturated	NULL
solution	NULL
with	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
mM	NULL
(	NULL
14	NULL
)	NULL
,	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
as	NULL
NO	NULL
solutions	NULL
(	NULL
10	NULL
)	NULL
.	NULL

PHJGDP	NULL
Release	NULL
Assay-p23V	NULL
®	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
GDP	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mg/ml	NULL
BSA	NULL
,	NULL
and	NULL
100	NULL
pmol	NULL
of	NULL
[	NULL
°HJGDP	NULL
(	NULL
10	NULL
Ci/mmol	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
20	NULL
pl	NULL
of	NULL
5	NULL
mM	NULL
GTP	NULL
was	NULL
added	NULL
with	NULL
any	NULL
test	NULL
reagents	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
the	NULL
required	NULL
time	NULL
at	NULL
30	NULL
°C	NULL
,	NULL
40-ul	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
bound	NULL
[	NULL
°HJGDP	NULL
was	NULL
separated	NULL
from	NULL
free	NULL
by	NULL
washing	NULL
with	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
25	NULL
mm	NULL
MgCl	NULL
,	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
dried	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

Binding	NULL
Assay-The	NULL
y-*°S-GTP	NULL
binding	NULL
assay	NULL
was	NULL
performed	NULL
exactly	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
,	NULL
except	NULL
that	NULL
100	NULL
nM	NULL
y-S-GTP	NULL
was	NULL
added	NULL
to	NULL
modify	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Assay	NULL
of	NULL
Nitrosothiol	NULL
Content-Samples	NULL
of	NULL
p21	NULL
``	NULL
**	NULL
were	NULL
exposed	NULL
to	NULL
NO	NULL
(	NULL
50	NULL
pM	NULL
)	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
analysis	NULL
of	NULL
nitrosothiol	NULL
content	NULL
by	NULL
a	NULL
coloro-metric	NULL
method	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Samples	NULL
containing	NULL
either	NULL
NO	NULL
,	NULL
p21	NULL
``	NULL
,	NULL
or	NULL
IgG	NULL
alone	NULL
had	NULL
no	NULL
detectable	NULL
nitrosothiol	NULL
.	NULL

S-Nitroso-N-acetylpeniciliamine	NULL
(	NULL
10-1000	NULL
uM	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Circular	NULL
Dichroism	NULL
Spectral	NULL
Analysis-Circular	NULL
dichroism	NULL
spectral	NULL
analysis	NULL
was	NULL
performed	NULL
at	NULL
22	NULL
°C	NULL
in	NULL
0.1-mm	NULL
cuvettes	NULL
in	NULL
a	NULL
Jasco	NULL
710	NULL
CD	NULL
spectrophotometer	NULL
.	NULL

Samples	NULL
were	NULL
dissolved	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
buffer	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
measured	NULL
with	NULL
a	NULL
0.2-nm	NULL
bandwidth	NULL
,	NULL
a	NULL
0.2	NULL
nm	NULL
step	NULL
scan	NULL
,	NULL
and	NULL
varying	NULL
scan	NULL
speeds	NULL
of	NULL
60-200	NULL
nm/min	NULL
.	NULL

NO	NULL
(	NULL
50	NULL
um	NULL
)	NULL
was	NULL
added	NULL
to	NULL
p21	NULL
``	NULL
**	NULL
(	NULL
17	NULL
pM	NULL
)	NULL
,	NULL
and	NULL
spectral	NULL
characteristics	NULL
measured	NULL
over	NULL
varying	NULL
time	NULL
periods	NULL
indicated	NULL
that	NULL
p21	NULL
'	NULL
``	NULL
*	NULL
``	NULL
and	NULL
the	NULL
p21	NULL
``	NULL
``	NULL
*-NO	NULL
complex	NULL
remained	NULL
stable	NULL
for	NULL
the	NULL
duration	NULL
of	NULL
the	NULL
data	NULL
collection	NULL
period	NULL
.	NULL

The	NULL
spectra	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
LINCOMB	NULL
program	NULL
(	NULL
Dr.	NULL
G.	NULL
D.	NULL
Fasman	NULL
,	NULL
Brandeis	NULL
University	NULL
,	NULL
Waltham	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
Gel	NULL
Shift	NULL
Assay-Nuclei	NULL
from	NULL
PC12	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
assayed	NULL
for	NULL
NF-kB	NULL
binding	NULL
activity	NULL
as	NULL
we	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Effects	NULL
of	NULL
NO	NULL
on	NULL
p21	NULL
Enzymology-In	NULL
its	NULL
resting	NULL
state	NULL
,	NULL
p21	NULL
``	NULL
**	NULL
has	NULL
GDP	NULL
bound	NULL
.	NULL

Upon	NULL
in	NULL
vivo	NULL
activation	NULL
,	NULL
p21	NULL
``	NULL
releases	NULL
GDP	NULL
and	NULL
binds	NULL
GTP	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

To	NULL
test	NULL
if	NULL
NO	NULL
activates	NULL
p21	NULL
*	NULL
``	NULL
,	NULL
we	NULL
7017	NULL
7018	NULL
200	NULL
150	NULL
7	NULL
(	NULL
¥	NULL
of	NULL
Control	NULL
}	NULL
[	NULL
>	NULL
ras	NULL
&	NULL
OO	NULL
T	NULL
f	NULL
'	NULL
l	NULL
100	NULL
4	NULL
a.	NULL
T	NULL
i-	NULL
/	NULL
,	NULL
/	NULL
&	NULL
D	NULL
T	NULL
mi	NULL
T	NULL
T-	NULL
U	NULL
0.001	NULL
0.01	NULL
0.1	NULL
1	NULL
10	NULL
NO	NULL
(	NULL
pM	NULL
)	NULL
150	NULL
T	NULL
6	NULL
L_	NULL
5	NULL
C	NULL
o	NULL
&	NULL
20128	NULL
7	NULL
s	NULL
3€	NULL
w/	NULL
w	NULL
Ke	NULL
x	NULL
,	NULL
100	NULL
«	NULL
CI	NULL
``	NULL
|	NULL
a	NULL
i-	NULL
/	NULL
/	NULL
°	NULL
11	NULL
.	NULL

A1	NULL
0	NULL
T	NULL
I	NULL
T	NULL
I	NULL
T	NULL
I	NULL
I	NULL
I	NULL
000	NULL
50	NULL
4g	NULL
O50	NULL
200	NULL
250	NULL
300	NULL
35	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
,	NULL
Effect	NULL
of	NULL
NO	NULL
on	NULL
p21	NULL
``	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
stimulated	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
NO	NULL
for	NULL
10	NULL
min	NULL
(	NULL
A	NULL
)	NULL
or	NULL
with	NULL
NO	NULL
(	NULL
0.01	NULL
um	NULL
)	NULL
for	NULL
various	NULL
times	NULL
(	NULL
B	NULL
)	NULL
.	NULL

At	NULL
the	NULL
appropriate	NULL
times	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
the	NULL
bound	NULL
nucleotides	NULL
analyzed	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
GTP-bound	NULL
p21	NULL
**	NULL
of	NULL
control	NULL
.	NULL

Control	NULL
samples	NULL
had	NULL
a	NULL
base	NULL
line	NULL
value	NULL
of	NULL
12.4	NULL
+	NULL
3.6	NULL
%	NULL
GTP	NULL
bound	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
from	NULL
four	NULL
to	NULL
six	NULL
experiments	NULL
.	NULL

measured	NULL
the	NULL
ratio	NULL
of	NULL
GTP/GDP	NULL
on	NULL
p21	NULL
``	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
)	NULL
in	NULL
which	NULL
the	NULL
nucleotide	NULL
pools	NULL
were	NULL
labeled	NULL
with	NULL
°°PO	NULL
;	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
immunoprecipitation	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
reveals	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
GTP	NULL
bound	NULL
upon	NULL
NO	NULL
treatment	NULL
.	NULL

The	NULL
curve	NULL
is	NULL
biphasic	NULL
with	NULL
a	NULL
maximal	NULL
effect	NULL
at	NULL
10	NULL
nm	NULL
,	NULL
although	NULL
higher	NULL
concentrations	NULL
of	NULL
NO	NULL
yielded	NULL
levels	NULL
of	NULL
GTP-p21	NULL
``	NULL
*	NULL
``	NULL
that	NULL
were	NULL
above	NULL
base	NULL
line	NULL
values	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
p21	NULL
**	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
is	NULL
of	NULL
short	NULL
duration	NULL
and	NULL
more	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
upon	NULL
growth	NULL
factor	NULL
receptor	NULL
stimulation	NULL
of	NULL
neural	NULL
cells	NULL
than	NULL
that	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
relatively	NULL
short	NULL
duration	NULL
of	NULL
the	NULL
NO-induced	NULL
signal	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
activated	NULL
p21	NULL
°	NULL
with	NULL
its	NULL
effector	NULL
and/or	NULL
GTPase-activating	NULL
proteins	NULL
.	NULL

Alternatively	NULL
,	NULL
this	NULL
stimulation	NULL
may	NULL
be	NULL
transient	NULL
and	NULL
therefore	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
fully	NULL
activated	NULL
phenotype	NULL
.	NULL

The	NULL
activating	NULL
effect	NULL
of	NULL
NO	NULL
could	NULL
be	NULL
mediated	NULL
either	NULL
by	NULL
direct	NULL
interaction	NULL
with	NULL
p21	NULL
``	NULL
**	NULL
or	NULL
indirectly	NULL
through	NULL
additional	NULL
factors	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
mixed	NULL
NO	NULL
with	NULL
pure	NULL
recombinant	NULL
p21	NULL
**	NULL
in	NULL
vitro	NULL
and	NULL
measured	NULL
its	NULL
intrinsic	NULL
GTPase	NULL
activity	NULL
.	NULL

Surprisingly	NULL
,	NULL
NO	NULL
enhanced	NULL
the	NULL
GTPase	NULL
activity	NULL
of	NULL
p21	NULL
in	NULL
vitro	NULL
,	NULL
indicating	NULL
a	NULL
direct	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Co-incubation	NULL
with	NULL
catalase	NULL
(	NULL
1000	NULL
Nitric	NULL
Oxide	NULL
Signaling	NULL
through	NULL
p21	NULL
b	NULL
160	NULL
s	NULL
an	NULL
o	NULL
NO	NULL
(	NULL
b	NULL
2	NULL
;	NULL
120	NULL
e	NULL
CO	NULL
a	NULL
~	NULL
3	NULL
o	NULL
®	NULL
a	NULL
E	NULL
so	NULL
(	NULL
f	NULL
)	NULL
t	NULL
C	NULL
6	NULL
a	NULL
_-8	NULL
E	NULL
40	NULL
--	NULL
hat	NULL
®	NULL
--	NULL
A	NULL
o	NULL
o	NULL
+4	NULL
+	NULL
r	NULL
r	NULL
.	NULL

-+-o	NULL
20	NULL
40	NULL
so	NULL
so	NULL
100	NULL
Gos	NULL
(	NULL
uM	NULL
)	NULL
100	NULL
B0	NULL
]	NULL
CS4	NULL
s	NULL
|-	NULL
250	NULL
'	NULL
g	NULL
g	NULL
Bo	NULL
\o	NULL
g	NULL
~	NULL
[	NULL
ea	NULL
)	NULL
\	NULL
%	NULL
frr	NULL
TE	NULL
a.	NULL
in	NULL
£	NULL
&	NULL
5	NULL
200	NULL
8	NULL
6	NULL
C	NULL
L	NULL
9	NULL
_	NULL
,	NULL
«	NULL
0	NULL
6	NULL
I	NULL
%	NULL
a.	NULL
x®	NULL
+150	NULL
6	NULL
&	NULL
0	NULL
20	NULL
+	NULL
|	NULL
©	NULL
._/	NULL
i	NULL
0	NULL
’	NULL
i	NULL
if	NULL
100	NULL
$	NULL
o	NULL
1	NULL
10	NULL
100	NULL
NO	NULL
(	NULL
uM	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
NO	NULL
and	NULL
carbon	NULL
monoxide	NULL
on	NULL
p21	NULL
``	NULL
enzymatic	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

Pure	NULL
recombinant	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
was	NULL
incubated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
NO	NULL
or	NULL
CO	NULL
for	NULL
10	NULL
min	NULL
(	NULL
4	NULL
)	NULL
after	NULL
which	NULL
p21	NULL
``	NULL
*	NULL
GTPase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

p21	NULL
``	NULL
preloaded	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
JGDP	NULL
,	NULL
or	NULL
GDP-loaded	NULL
p21	NULL
mixed	NULL
with	NULL
y-*°S-GTP	NULL
,	NULL
was	NULL
treated	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
NO	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
followed	NULL
by	NULL
assay	NULL
of	NULL
bound	NULL
[	NULL
°HJGDP	NULL
or	NULL
y-*°S-GTP	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
from	NULL
three	NULL
to	NULL
seven	NULL
experiments	NULL
.	NULL

unitsm1l	NULL
)	NULL
or	NULL
superoxide	NULL
dismutase	NULL
(	NULL
30	NULL
units/ml	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
/ability	NULL
of	NULL
NO	NULL
to	NULL
enhance	NULL
p21	NULL
``	NULL
**	NULL
GTPase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
activating	NULL
species	NULL
is	NULL
not	NULL
hydroxyl	NULL
radical	NULL
,	NULL
superoxide	NULL
,	NULL
or	NULL
peroxynitrite	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
NO	NULL
which	NULL
gives	NULL
a	NULL
maximal	NULL
response	NULL
(	NULL
75	NULL
um	NULL
)	NULL
in	NULL
vitro	NULL
is	NULL
much	NULL
higher	NULL
than	NULL
that	NULL
required	NULL
in	NULL
whole	NULL
cells	NULL
(	NULL
0.01	NULL
um	NULL
,	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
previously	NULL
a	NULL
similar	NULL
differential	NULL
sensitivity	NULL
in	NULL
leukocyte	NULL
membranes	NULL
treated	NULL
with	NULL
NO	NULL
before	NULL
or	NULL
after	NULL
isolation	NULL
using	NULL
a	NULL
membrane	NULL
GTPase	NULL
assay	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
phenomenon	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
cellular	NULL
component	NULL
which	NULL
makes	NULL
NO	NULL
more	NULL
potent	NULL
and	NULL
is	NULL
lacking	NULL
in	NULL
purified	NULL
preparations	NULL
.	NULL

These	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
oxidizing	NULL
conditions	NULL
which	NULL
favor	NULL
formation	NULL
of	NULL
nitrosonium	NULL
ion	NULL
(	NULL
NO¢	NULL
)	NULL
and	NULL
facilitate	NULL
nitrosothiol	NULL
formation	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NO	NULL
,	NULL
carbon	NULL
monoxide	NULL
,	NULL
another	NULL
gas	NULL
claimed	NULL
to	NULL
be	NULL
a	NULL
signaling	NULL
molecule	NULL
in	NULL
the	NULL
brain	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
p21	NULL
*	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
increase	NULL
in	NULL
GTPase	NULL
activity	NULL
could	NULL
be	NULL
due	NULL
to	NULL
either	NULL
:	NULL
1	NULL
)	NULL
an	NULL
increase	NULL
in	NULL
GDP	NULL
release	NULL
from	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
(	NULL
the	NULL
rate-limiting	NULL
step	NULL
in	NULL
the	NULL
catalytic	NULL
cycle	NULL
)	NULL
or	NULL
2	NULL
)	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
intrinsic	NULL
GTPase	NULL
activity	NULL
of	NULL
p21	NULL
``	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
GDP	NULL
release	NULL
is	NULL
controlled	NULL
by	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factors	NULL
(	NULL
GEF	NULL
)	NULL
,	NULL
and	NULL
represents	NULL
activation	NULL
,	NULL
whereas	NULL
GTP	NULL
hydrolysis	NULL
is	NULL
controlled	NULL
by	NULL
GTPase-activating	NULL
proteins	NULL
and	NULL
represents	NULL
inactivation	NULL
(	NULL
17	NULL
Nitric	NULL
Oxide	NULL
Signaling	NULL
through	NULL
p21	NULL
Hb	NULL
before	NULL
NO	NULL
Hb	NULL
after	NULL
NO	NULL
>	NULL
l	NULL
2	NULL
&	NULL
|	NULL
pie	NULL
1	NULL
<	NULL
o	NULL
i	NULL
3	NULL
ag-f	NULL
150	NULL
i	NULL
&	NULL
0	NULL
(	NULL
Eoul	NULL
I	NULL
0	NULL
G	NULL
|	NULL
10	NULL
i	NULL
-	NULL
1	NULL
§	NULL
|	NULL
I	NULL
1	NULL
l	NULL
N0	NULL
:	NULL
-o	NULL
¢	NULL
t	NULL
-	NULL
+	NULL
+	NULL
Hb	NULL
:	NULL
-	NULL
-	NULL
4+	NULL
+	NULL
-o	NULL
q	NULL
B	NULL
{	NULL
Z2	NULL
R-SNO	NULL
Formation	NULL
(	NULL
mol/me	NULL
!	NULL
)	NULL

0	NULL
1	NULL
2	NULL
0	NULL
*	NULL
Y13-259	NULL
Sos	NULL
Y13-238	NULL
NO	NULL
NO	NULL
+	NULL
Y1	NULL
3-259	NULL
ies	NULL
NO	NULL
+	NULL
¥13~-238	NULL
0	NULL
1	NULL
2	NULL
BML	NULL
p21	NULL
``	NULL
GTPase	NULL
Activity	NULL
(	NULL
Fold	NULL
Stimulation	NULL
)	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
hemoglobin	NULL
and	NULL
the	NULL
influence	NULL
of	NULL
blocking	NULL
antibodies	NULL
on	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
activity	NULL
and	NULL
nitrosothiol	NULL
formation	NULL
.	NULL

Hb	NULL
(	NULL
0.4	NULL
mM	NULL
)	NULL
was	NULL
added	NULL
before	NULL
or	NULL
10	NULL
min	NULL
after	NULL
NO	NULL
(	NULL
100	NULL
um	NULL
)	NULL
addition	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
antibody	NULL
blocking	NULL
experiments	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
antibody	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
um	NULL
p21	NULL
``	NULL
for	NULL
30	NULL
min	NULL
at	NULL
22	NULL
°C	NULL
followed	NULL
by	NULL
NO	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
addition	NULL
and	NULL
GTPase	NULL
assay	NULL
or	NULL
nitrosothiol	NULL
assay	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

The	NULL
asterisk	NULL
denotes	NULL
no	NULL
detectable	NULL
nitrosothiols	NULL
(	NULL
i.e	NULL
.	NULL

less	NULL
than	NULL
0.2	NULL
mol/mol	NULL
)	NULL
.	NULL

20	NULL
)	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
we	NULL
preloaded	NULL
p2V	NULL
*	NULL
with	NULL
[	NULL
PHJGDP	NULL
and	NULL
tested	NULL
whether	NULL
NO	NULL
increased	NULL
GDP	NULL
release	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
concentrations	NULL
of	NULL
NO	NULL
which	NULL
enhance	NULL
GTPase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
induced	NULL
GDP	NULL
release	NULL
from	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
.	NULL

Furthermore	NULL
,	NULL
at	NULL
concentrations	NULL
of	NULL
NO	NULL
where	NULL
[	NULL
°H	NULL
]	NULL
JGDP	NULL
was	NULL
released	NULL
,	NULL
y-*°S-GTP	NULL
was	NULL
bound	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
our	NULL
findings	NULL
of	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
GTP/GDP	NULL
ratio	NULL
on	NULL
p21	NULL
``	NULL
**	NULL
in	NULL
whole	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
verify	NULL
the	NULL
concept	NULL
that	NULL
NO	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
p21	NULL
``	NULL
by	NULL
promoting	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
.	NULL

Studies	NULL
on	NULL
Mechanism-Hemoglobin	NULL
(	NULL
Hb	NULL
)	NULL
has	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
NO	NULL
and	NULL
can	NULL
thus	NULL
prevent	NULL
most	NULL
of	NULL
its	NULL
biological	NULL
actions	NULL
by	NULL
complexing	NULL
with	NULL
it	NULL
(	NULL
23	NULL
,	NULL
28	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Hb	NULL
prevented	NULL
NO	NULL
from	NULL
activating	NULL
p21	NULL
``	NULL
when	NULL
added	NULL
prior	NULL
to	NULL
NO	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
Hb	NULL
was	NULL
added	NULL
10	NULL
min	NULL
after	NULL
NO	NULL
addition	NULL
,	NULL
p21	NULL
``	NULL
activation	NULL
was	NULL
reversed	NULL
whereas	NULL
Hb	NULL
by	NULL
itself	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

A	NULL
reversible	NULL
activation	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
by	NULL
NO	NULL
implies	NULL
that	NULL
either	NULL
NO	NULL
is	NULL
acting	NULL
allosterically	NULL
or	NULL
that	NULL
it	NULL
reversibly	NULL
and	NULL
covalently	NULL
modifies	NULL
an	NULL
enzyme	NULL
site	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
nitrosothiols	NULL
are	NULL
known	NULL
to	NULL
be	NULL
reversibly	NULL
nitrosated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Hb	NULL
(	NULL
23	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
GDP	NULL
is	NULL
effected	NULL
by	NULL
GEF	NULL
's	NULL
which	NULL
bind	NULL
to	NULL
regions	NULL
on	NULL
p21	NULL
``	NULL
that	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
monoclonal	NULL
antibody	NULL
Y13-259	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
NO	NULL
induces	NULL
GDP	NULL
release	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
GEF	NULL
's	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
preincubation	NULL
of	NULL
p21	NULL
``	NULL
**	NULL
with	NULL
Y13-259	NULL
prevents	NULL
NO	NULL
activation	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
antibody	NULL
Y13-259	NULL
substantially	NULL
prevented	NULL
the	NULL
ability	NULL
of	NULL
NO	NULL
to	NULL
activate	NULL
p21	NULL
``	NULL
**	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
monoclonal	NULL
antibody	NULL
Y13-238	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
different	NULL
region	NULL
on	NULL
the	NULL
molecule	NULL
(	NULL
31	NULL
)	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NO	NULL
induces	NULL
GDP	NULL
7019	NULL
1	NULL
``	NULL
which	NULL
normally	NULL
release	NULL
by	NULL
interacting	NULL
with	NULL
a	NULL
region	NULL
of	NULL
p2	NULL
interacts	NULL
with	NULL
GEK	NULL
's	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Because	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
heme	NULL
group	NULL
,	NULL
and	NULL
Hb	NULL
reversed	NULL
the	NULL
activation	NULL
by	NULL
NO	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
was	NULL
via	NULL
formation	NULL
of	NULL
a	NULL
nitrosothiol	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
NO	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
only	NULL
one	NULL
nitrosothiol	NULL
on	NULL
p21	NULL
``	NULL
,	NULL
even	NULL
though	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
contains	NULL
5	NULL
Cys	NULL
resi-dues	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
antibody	NULL
Y13-259	NULL
,	NULL
which	NULL
prevented	NULL
activation	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
*	NULL
``	NULL
by	NULL
NO	NULL
,	NULL
also	NULL
prevented	NULL
nitrosothiol	NULL
formation	NULL
,	NULL
whereas	NULL
the	NULL
control	NULL
antibody	NULL
Y13-238	NULL
,	NULL
which	NULL
did	NULL
not	NULL
prevent	NULL
activation	NULL
,	NULL
also	NULL
did	NULL
not	NULL
prevent	NULL
nitrosothiol	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Hg	NULL
``	NULL
*	NULL
,	NULL
a	NULL
known	NULL
thiol-reactive	NULL
reagent	NULL
,	NULL
enhanced	NULL
p21	NULL
``	NULL
GTPase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
formation	NULL
of	NULL
a	NULL
nitrosothiol	NULL
on	NULL
p21	NULL
**	NULL
by	NULL
NO	NULL
is	NULL
responsible	NULL
for	NULL
activation	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
NO	NULL
causes	NULL
a	NULL
conformational	NULL
alteration	NULL
in	NULL
p21	NULL
``	NULL
,	NULL
we	NULL
used	NULL
circular	NULL
dichroism	NULL
(	NULL
CD	NULL
)	NULL
spectral	NULL
analysis	NULL
to	NULL
assess	NULL
secondary	NULL
structure	NULL
.	NULL

Treatment	NULL
of	NULL
p21	NULL
**	NULL
with	NULL
NO	NULL
led	NULL
to	NULL
a	NULL
dramatic	NULL
change	NULL
in	NULL
its	NULL
CD	NULL
spectral	NULL
properties	NULL
,	NULL
and	NULL
computer	NULL
analysis	NULL
revealed	NULL
a	NULL
profound	NULL
reduction	NULL
in	NULL
a-helical	NULL
content	NULL
(	NULL
from	NULL
60	NULL
to	NULL
36	NULL
%	NULL
)	NULL
and	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
B-sheet	NULL
content	NULL
(	NULL
from	NULL
18	NULL
to	NULL
44	NULL
%	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
spectra	NULL
we	NULL
obtained	NULL
for	NULL
untreated	NULL
p21	NULL
**	NULL
were	NULL
identical	NULL
to	NULL
that	NULL
published	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NO	NULL
induces	NULL
a	NULL
conformational	NULL
change	NULL
in	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
concomitant	NULL
upon	NULL
nitrosothiol	NULL
formation	NULL
,	NULL
leading	NULL
to	NULL
enhanced	NULL
nucleotide	NULL
exchange	NULL
.	NULL

Downstream	NULL
Signaling-Previous	NULL
data	NULL
from	NULL
our	NULL
laboratory	NULL
have	NULL
broadened	NULL
the	NULL
spectrum	NULL
of	NULL
NO	NULL
action	NULL
to	NULL
include	NULL
an	NULL
immune	NULL
stimulatory	NULL
component	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

In	NULL
those	NULL
studies	NULL
a	NULL
G	NULL
protein	NULL
inhibitor	NULL
,	NULL
GDPBS	NULL
,	NULL
blocked	NULL
NO-induced	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
activation	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Although	NULL
those	NULL
findings	NULL
implicated	NULL
(	NULL
G	NULL
proteins	NULL
as	NULL
transducers	NULL
of	NULL
NO	NULL
signals	NULL
,	NULL
exactly	NULL
which	NULL
G	NULL
proteins	NULL
were	NULL
involved	NULL
was	NULL
unclear	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
NO	NULL
could	NULL
activate	NULL
NF-KB	NULL
in	NULL
cells	NULL
harboring	NULL
a	NULL
mutant	NULL
,	NULL
inactive	NULL
p21	NULL
®	NULL
(	NULL
35	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
wild	NULL
type	NULL
parental	NULL
cells	NULL
responded	NULL
to	NULL
sodium	NULL
ni-troprusside	NULL
by	NULL
translocating	NULL
NF-B	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
p21	NULL
``	NULL
**-defective	NULL
cells	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
sodium	NULL
nitroprus-side	NULL
.	NULL

Thus	NULL
,	NULL
p21	NULL
``	NULL
*	NULL
is	NULL
necessary	NULL
for	NULL
NO-induced	NULL
cellular	NULL
activation	NULL
signals	NULL
.	NULL

Others	NULL
have	NULL
found	NULL
that	NULL
PC12	NULL
cells	NULL
expressing	NULL
a	NULL
dominant	NULL
negative	NULL
mutation	NULL
in	NULL
p21	NULL
``	NULL
no	NULL
longer	NULL
respond	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
and	NULL
UV	NULL
light	NULL
by	NULL
activating	NULL
NF-kB	NULL
(	NULL
36	NULL
)	NULL
.	NULL

These	NULL
free	NULL
radical	NULL
generators	NULL
(	NULL
4	NULL
)	NULL
were	NULL
proposed	NULL
to	NULL
act	NULL
upstream	NULL
of	NULL
``	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
reactive	NULL
nitrogen	NULL
species	NULL
,	NULL
and	NULL
therefore	NULL
possibly	NULL
reactive	NULL
oxygen	NULL
species	NULL
,	NULL
directly	NULL
activate	NULL
p21	NULL
,	NULL
leading	NULL
to	NULL
subsequent	NULL
downstream	NULL
events	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

The	NULL
physiological	NULL
relevance	NULL
of	NULL
our	NULL
findings	NULL
are	NULL
strengthened	NULL
by	NULL
our	NULL
demonstration	NULL
that	NULL
endogenous	NULL
NO	NULL
activates	NULL
p21	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
induced	NULL
nitric	NULL
oxide	NULL
synthesis	NULL
in	NULL
HUVEC	NULL
with	NULL
LPS	NULL
and	NULL
IFN-y	NULL
(	NULL
37	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
nitric	NULL
oxide	NULL
synthase	NULL
inhibitor	NULL
``	NULL
N-methyl-L-argi-nine	NULL
,	NULL
providing	NULL
a	NULL
pulse	NULL
of	NULL
the	NULL
substrate	NULL
,	NULL
L-arginine	NULL
(	NULL
to	NULL
avoid	NULL
the	NULL
desensitization	NULL
effect	NULL
found	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
led	NULL
to	NULL
recovery	NULL
of	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
p21	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
auto-crine	NULL
loop	NULL
may	NULL
exist	NULL
within	NULL
cells	NULL
,	NULL
whereby	NULL
endogenous	NULL
NO	NULL
activates	NULL
cellular	NULL
p21	NULL
,	NULL
leading	NULL
to	NULL
cell	NULL
activation	NULL
and	NULL
nitric	NULL
oxide	NULL
synthase	NULL
transcriptional	NULL
regulation	NULL
.	NULL

NO	NULL
is	NULL
a	NULL
highly	NULL
reactive	NULL
gas	NULL
which	NULL
can	NULL
be	NULL
generated	NULL
in	NULL
high	NULL
local	NULL
concentrations	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
p21	NULL
*	NULL
by	NULL
NO	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
major	NULL
mechanism	NULL
of	NULL
amplification	NULL
of	NULL
leukocyte-induced	NULL
local	NULL
tissue	NULL
damage	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
identify	NULL
p21	NULL
``	NULL
**	NULL
as	NULL
a	NULL
target	NULL
of	NULL
NO	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
NO	NULL
,	NULL
via	NULL
formation	NULL
of	NULL
a	NULL
nitrosothiol	NULL
,	NULL
leads	NULL
to	NULL
a	NULL
conformational	NULL
change	NULL
which	NULL
enhances	NULL
guanine	NULL
nucleotide	NULL
7020	NULL
A	NULL
wt	NULL
(	NULL
ras+	NULL
)	NULL
mt	NULL
(	NULL
ras-	NULL
)	NULL
SNP	NULL
(	NULL
uM	NULL
)	NULL
:	NULL
0	NULL
1	NULL
10	NULL
0	NULL
1	NULL
10	NULL
NF	NULL
-	NULL
KB	NULL
B	NULL
so	NULL
-	NULL
it	NULL
``	NULL
%	NULL
No	NULL
Addition	NULL
fos	NULL
IFN-y	NULL
x*	NULL
40	NULL
0	NULL
U	NULL
L.	NULL
YC	NULL
-	NULL
30	NULL
4	NULL
OO	NULL
Q	NULL
ere	NULL
Q	NULL
i—	NULL
J	NULL
ip	NULL
.	NULL

0	NULL
NMA	NULL
:	NULL
o-	NULL
0	NULL
+	NULL
00+	NULL
sok	NULL
og	NULL
ARG	NULL
:	NULL
-	NULL
-	NULL
+	NULL
i	NULL
a	NULL
£	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Role	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
in	NULL
NO	NULL
signaling	NULL
.	NULL

Upper	NULL
panel	NULL
,	NULL
parental	NULL
PC12	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
ras-negative	NULL
(	NULL
mt	NULL
)	NULL
cells	NULL
were	NULL
serum-starved	NULL
overnight	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
concentration	NULL
of	NULL
sodium	NULL
nitroprus-side	NULL
(	NULL
SNP	NULL
)	NULL
,	NULL
an	NULL
NO-generating	NULL
compound	NULL
,	NULL
for	NULL
4	NULL
h	NULL
followed	NULL
by	NULL
nucleus	NULL
isolation	NULL
and	NULL
assay	NULL
for	NULL
NF-kB	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
arrow	NULL
denotes	NULL
migration	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/DNA	NULL
complex	NULL
.	NULL

Lower	NULL
panel	NULL
,	NULL
HUVECs	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
16	NULL
h	NULL
with	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
,	NULL
30	NULL
ug/	NULL
ml	NULL
)	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
,	NULL
50	NULL
ng/ml	NULL
)	NULL
or	NULL
``	NULL
N-methyl-L-arginine	NULL
(	NULL
NMA	NULL
)	NULL
(	NULL
3	NULL
mm	NULL
)	NULL
in	NULL
phosphate-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
100	NULL
mCi/ml	NULL
*°PO	NULL
;	NULL
.	NULL

Then	NULL
,	NULL
indicated	NULL
wells	NULL
were	NULL
treated	NULL
with	NULL
L-arginine	NULL
(	NULL
ARG	NULL
,	NULL
10	NULL
mm	NULL
)	NULL
for	NULL
15	NULL
min	NULL
and	NULL
samples	NULL
assayed	NULL
for	NULL
GTP-bound	NULL
p21	NULL
``	NULL
.	NULL

exchange	NULL
,	NULL
thus	NULL
mimicking	NULL
endogenous	NULL
GEF	NULL
's	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
NO	NULL
to	NULL
activate	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
,	NULL
a	NULL
non-heme	NULL
enzyme	NULL
,	NULL
represents	NULL
a	NULL
novel	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Furthermore	NULL
,	NULL
because	NULL
nitrosothiol	NULL
formation	NULL
on	NULL
a	NULL
critical	NULL
cysteine	NULL
is	NULL
apparently	NULL
responsible	NULL
for	NULL
its	NULL
activation	NULL
,	NULL
p21	NULL
``	NULL
may	NULL
be	NULL
ideally	NULL
suited	NULL
to	NULL
transduce	NULL
other	NULL
oxidative	NULL
stress	NULL
signals	NULL
from	NULL
both	NULL
endogenous	NULL
and	NULL
exog-enous	NULL
sources	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
others	NULL
have	NULL
found	NULL
that	NULL
redox	NULL
agents	NULL
modulate	NULL
binding	NULL
of	NULL
GTP	NULL
to	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
immuno-precipitates	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
**	NULL
or	NULL
other	NULL
monomeric	NULL
G	NULL
proteins	NULL
by	NULL
NO	NULL
may	NULL
not	NULL
be	NULL
restricted	NULL
to	NULL
T	NULL
cells	NULL
and	NULL
conceivably	NULL
could	NULL
mediate	NULL
many	NULL
signals	NULL
transmitted	NULL
by	NULL
NO	NULL
,	NULL
such	NULL
as	NULL
Ca**-independent	NULL
vesicle	NULL
exocytosis	NULL
(	NULL
39	NULL
)	NULL
and	NULL
synaptic	NULL
plasticity	NULL
in	NULL
the	NULL
brain	NULL
(	NULL
8	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Heterotrimeric	NULL
G	NULL
proteins	NULL
may	NULL
also	NULL
be	NULL
a	NULL
target	NULL
of	NULL
NO	NULL
as	NULL
the	NULL
G	NULL
,	NULL
,	NULL
subunits	NULL
are	NULL
highly	NULL
homologous	NULL
to	NULL
p21	NULL
``	NULL
(	NULL
18	NULL
)	NULL
.	NULL

For	NULL
example	NULL
G	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
Nitric	NULL
Oxide	NULL
Signaling	NULL
through	NULL
p21'®	NULL
mediate	NULL
olfaction	NULL
,	NULL
and	NULL
NO	NULL
has	NULL
recently	NULL
been	NULL
implicated	NULL
in	NULL
this	NULL
sytem	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
D.	NULL
Manor	NULL
,	NULL
Cornell	NULL
University	NULL
,	NULL
Ithaca	NULL
,	NULL
NY	NULL
for	NULL
generously	NULL
providing	NULL
the	NULL
purified	NULL
recombinant	NULL
p21	NULL
``	NULL
;	NULL
Dr.	NULL
G.	NULL
Cooper	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
,	NULL
for	NULL
the	NULL
mutant	NULL
PC12	NULL
cell	NULL
line	NULL
;	NULL
and	NULL
Dr.	NULL
Steven	NULL
S.	NULL
Gross	NULL
for	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Novogrodsky	NULL
,	NULL
A.	NULL
,	NULL
Ravid	NULL
,	NULL
A.	NULL
,	NULL
Rubin	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Stenzel	NULL
,	NULL
K.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
1171-1174	NULL
.	NULL

Whitacre	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Cathcart	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
287-295	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
Gougerot-Pocidalo	NULL
,	NULL
M.-A	NULL
.	NULL

,	NULL
Aillet	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Verelizier	NULL
,	NULL
J.-L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
3386-3393	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
.	NULL

Nathan	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3051-3064	NULL
.	NULL

Dinerman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Lowenstein	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Circ	NULL
.	NULL

Res	NULL
.	NULL

73	NULL
,	NULL
217-222	NULL
7	NULL
.	NULL

Karupiah	NULL
,	NULL
G.	NULL
,	NULL
Xie	NULL
,	NULL
Q.-W.	NULL
,	NULL
Buller	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Nathan	NULL
,	NULL
C.	NULL
,	NULL
Duarte	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
MacMicking	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1445-1448	NULL
8	NULL
.	NULL

Schuman	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Madison	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
1503-1506	NULL
9	NULL
.	NULL

Lander	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Sehajpal	NULL
,	NULL
P.	NULL
,	NULL
Levine	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Novogrodsky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
1509-1516	NULL
10	NULL
.	NULL

Lander	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Sehajpal	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Novogrodsky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
7182-7187	NULL
11	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Warne	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Rayter	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
346	NULL
,	NULL
719-723	NULL
12	NULL
.	NULL

Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Downward	NULL
,	NULL
J.	NULL
,	NULL
Rayter	NULL
,	NULL
S.	NULL
,	NULL
Warne	NULL
,	NULL
P.	NULL
,	NULL
Tutt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
3709-3712	NULL
13	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
Graves	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
89-92	NULL
14	NULL
.	NULL

Budavari	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
The	NULL
Merck	NULL
Index	NULL
,	NULL
11th	NULL
Ed	NULL
.	NULL

,	NULL
p.	NULL
275	NULL
,	NULL
Merck	NULL
&	NULL
Co.	NULL
Inc.	NULL
,	NULL
Rahway	NULL
,	NULL
NJ	NULL
15	NULL
.	NULL

Carty	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Iyengar	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

237	NULL
,	NULL
38-44	NULL
16	NULL
.	NULL

Saville	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1958	NULL
)	NULL
Analyst	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

83	NULL
,	NULL
670-672	NULL
17	NULL
.	NULL

Satoh	NULL
,	NULL
T.	NULL
,	NULL
Nakafuku	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kaziro	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24149-24152	NULL
18	NULL
.	NULL

Bokoch	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
Der	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

7	NULL
,	NULL
750-759	NULL
19	NULL
.	NULL

Bourne	NULL
,	NULL
H.	NULL
,	NULL
Sanders	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
McCormick	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
849	NULL
,	NULL
117-127	NULL
20	NULL
.	NULL

Boguski	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
McCormick	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
643-654	NULL
21	NULL
.	NULL

Muroya	NULL
,	NULL
K.	NULL
,	NULL
Hattori	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nakamura	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
277-281	NULL
22	NULL
.	NULL

Li	NULL
,	NULL
B.-Q	NULL
.	NULL

,	NULL
Kaplan	NULL
,	NULL
D.	NULL
,	NULL
Kung	NULL
,	NULL
H.-F.	NULL
,	NULL
and	NULL
Kamata	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
1456-1459	NULL
23	NULL
.	NULL

Stamler	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Singel	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Loscalzo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
1898-1902	NULL
24	NULL
.	NULL

Stamler	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Simon	NULL
,	NULL
D.	NULL
I.	NULL
,	NULL
Osborne	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mullins	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Jaraki	NULL
,	NULL
O.	NULL
,	NULL
Michel	NULL
,	NULL
T.	NULL
,	NULL
Singel	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Loscalzo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
444-448	NULL
25	NULL
.	NULL

Lipton	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Choi	NULL
,	NULL
Y.-B	NULL
.	NULL

,	NULL
Pan	NULL
,	NULL
Z.-H.	NULL
,	NULL
Lei	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
Chen	NULL
,	NULL
H.-S.	NULL
V.	NULL
,	NULL
Sucher	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Loscalzo	NULL
,	NULL
J.	NULL
,	NULL
Singel	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Stamler	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
364	NULL
,	NULL
626-632	NULL
26	NULL
.	NULL

Zhuo	NULL
,	NULL
M.	NULL
,	NULL
Small	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Kandel	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Hawkins	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
1946-1950	NULL
27	NULL
.	NULL

Verma	NULL
,	NULL
A.	NULL
,	NULL
Hirsch	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Glatt	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Ronnett	NULL
,	NULL
G.	NULL
V.	NULL
,	NULL
and	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
381-384	NULL
28	NULL
.	NULL

Stamler	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
931-936	NULL
29	NULL
.	NULL

Sigal	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
Gibbs	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
D'Alonzo	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Skolnick	NULL
,	NULL
E.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4725-4729	NULL
30	NULL
.	NULL

Hattori	NULL
,	NULL
S.	NULL
,	NULL
Clanton	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Satch	NULL
,	NULL
T.	NULL
,	NULL
Nakumura	NULL
,	NULL
S.	NULL
,	NULL
Kaziro	NULL
,	NULL
Y.	NULL
,	NULL
Kawakita	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Shih	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
1999-2002	NULL
31	NULL
.	NULL

Furth	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Davis	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Fleurdelys	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Skolnick	NULL
,	NULL
E.	NULL
M.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

43	NULL
,	NULL
294-304	NULL
32	NULL
.	NULL

Quilliam	NULL
,	NULL
L.	NULL
,	NULL
Kato	NULL
,	NULL
K.	NULL
,	NULL
Rabun	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Hisaka	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Huff	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Campbell-Burk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Der	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1113-1121	NULL
33	NULL
.	NULL

Mosteller	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Broek	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1104-1112	NULL
34	NULL
.	NULL

Pingoud	NULL
,	NULL
A.	NULL
,	NULL
Wehrmann	NULL
,	NULL
M.	NULL
,	NULL
Pieper	NULL
,	NULL
U.	NULL
,	NULL
Gast	NULL
,	NULL
F.-U	NULL
.	NULL

,	NULL
Urbanke	NULL
,	NULL
C.	NULL
,	NULL
Alves	NULL
,	NULL
J.	NULL
,	NULL
Feuerstein	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Wittinghofer	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochemistry	NULL
27	NULL
,	NULL
4735-4740	NULL
35	NULL
.	NULL

Szeberenyi	NULL
,	NULL
J.	NULL
,	NULL
Cai	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Cooper	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5324-5332	NULL
36	NULL
.	NULL

Devary	NULL
,	NULL
Y.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1442-1445	NULL
37	NULL
.	NULL

Rosenkranz-Weiss	NULL
,	NULL
P.	NULL
,	NULL
Sessa	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Milstien	NULL
,	NULL
S.	NULL
,	NULL
Kaufman	NULL
,	NULL
S.	NULL
,	NULL
Watson	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Pober	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98	NULL
,	NULL
2236-2243	NULL
38	NULL
.	NULL

Wilkinson	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
Paulik	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Morre	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

190	NULL
,	NULL
229-235	NULL
39	NULL
.	NULL

Meffert	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Premack	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Schulman	NULL
,	NULL
H.	NULL
1235-1244	NULL
40	NULL
.	NULL

Schmidt	NULL
,	NULL
H.	NULL
H.	NULL
H.	NULL
W.	NULL
,	NULL
and	NULL
Walter	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
919-925	NULL
41	NULL
.	NULL

Gelperin	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
369	NULL
,	NULL
61-63	NULL
t	NULL
bo	NULL
&	NULL
Ot	NULL
m	NULL
(	NULL
1994	NULL
)	NULL
Neuron	NULL
12	NULL
,	NULL

